Omega 3 Fatty Acids

@Persej I was re-reading the thread infos (a 3rd round will be needed) and I wanted to share with you my awe and gratitude for the major dot-connecting you shared with us. I find it very impressive.

Thank you. I'm glad that you find it useful. I think that it is a very interesting topic, but still a little controversial. More studies are needed to confirm some of the hypothesis.

This one is also interesting. ARA and DHA are mobilized in the blood when we exercise, but the mobilization is reduced when we consume carbohydrates.

 
Omega 3s received a dire warning alert based on an observational study earlier this year, prompting many people to stop taking it or doctors to stop prescribing them.

Here's Rhonda Patrick's analysis on the subject:

Hello friends -

Regular listeners of the FoundMyFitness podcast will be well aware of my small obsession with omega-3s. But that’s only because they’re so important for overall health and wellness. Omega-3s are essential fats that play critical roles in neurodevelopment, cognitive function, immune response, inflammation control, cardiovascular health, cancer prevention, and healthy aging…and that’s just the start!

Fish oil is one fantastic source of omega-3s. And despite an abundance of evidence supporting the benefits of omega-3 fatty acids, there’s still the occasional study or meta-analysis that fails to find a benefit. Less often, a study gets published that raises a (false) alarm that fish oil might actually be harmful for some aspect of health.

That was the case recently, when a large observational study suggested that the regular use of fish oil may worsen the progression of cardiovascular diseases in some people. Not surprisingly, the media jumped all over this study with headlines warning of the dangers of fish oil.
Before getting into some of my qualms with the study, its limitations, and a discussion of why we should interpret these findings with caution, let’s actually get into the study itself.

The investigation was a prospective study that used data from the UK Biobank, a cohort of nearly half a million mostly white participants from the United Kingdom aged 40 to 65. A total of 415,737 participants were included in the current analysis. Importantly, none of these participants had cardiovascular diseases at baseline, according to self-reported and electronic health records. However, it's worth noting that these sources may not perfectly capture all health details.

On a single occasion, the participants completed a survey in which they indicated whether or not they were regular users of fish oil supplements by answering “yes” or “no.” This means that no information on duration of use, type of supplement used, formulation, or dosage was obtained.

The participants were monitored for a follow-up period of about 12 years, during which diagnoses of atrial fibrillation (Afib), major adverse cardiovascular events (i.e., heart attack, stroke, or heart failure), and death were recorded.

The researchers weren’t just interested in which disease the participants developed over the follow-up period, but rather, how their health progressed. Did the participants stay healthy, or did they transition into one of the diseases of interest or die?

This was accomplished by sorting the participants into one of 5 transition states based on their health trajectory:

  1. Participants who transitioned from healthy to Afib (transition A)
  2. Participants who transitioned from healthy to a major adverse cardiovascular event (transition B)
  3. Participants who transitioned from healthy to death (transition C)
  4. Participants who transitioned from Afib to a major adverse cardiovascular event (transition D)
  5. Participants who transitioned from Afib to death (transition E)
  6. Participants who transitioned from major adverse cardiovascular events to death (transition F)
667448183df01b9748b60a9a.jpg
Alright, now let’s take a look at the results.

Using fish oil supplements was associated with a 13% greater risk of developing Afib. On the other hand, fish oil use wasn’t associated with a greater risk of transitioning from healthy to a major adverse cardiovascular event or from health to death.

Among participants who developed Afib, using fish oil was associated with an 8% lower risk for transitioning to a major adverse cardiovascular event and a near-significant 9% lower risk for death. There was no association between using fish oil and transitioning from a major adverse cardiovascular event to death.

Here’s how the results looked when considering each individual major adverse cardiovascular event:

  • From health to major cardiovascular events: using fish oil was associated with an 8% lower risk of developing heart failure, a 5% increased risk of developing stroke, but no association was found for heart attack.
  • From Afib to major adverse cardiovascular events: using fish oil was associated with a 15% lower risk of developing a heart attack but was not associated with stroke or heart failure.
  • Among fish oil users, there was a 9% lower risk of transitioning from heart failure to death but no association for transitioning from stroke or heart attack to death.
667448200c0758857f01f6c1.png
The results of this study would suggest that as a primary prevention strategy, fish oil supplementation may not be useful and may in fact be harmful. But as a secondary prevention strategy among people who have developed early-stage or late-stage cardiovascular disease, fish oil use may provide protection.

Should you stop using fish oil if you’re healthy?

Before jumping to that conclusion, let’s put these risk increases in perspective. The healthy fish oil users had a 13% higher risk of Afib and a 5% higher risk of stroke compared to non-users — but this is in terms of relative risk. Relative risk represents a ratio of the risk of a cardiovascular event in the fish oil users compared to the risk in non-users. But relative risk doesn’t tell us much about absolute risk, or the absolute difference in the risk of a cardiovascular event between groups.

Without the raw data on the event rates in each group (how many participants experienced each event compared to those who didn’t), we can’t calculate the absolute risk for fish oil users and non-users in this study. But some personal correspondence with Dr. Bill Harris indicates that they may be much lower than the relative risks. For example, the actual incidence of Afib in the non-fish oil users was around 4.2%, while that in the fish oil users was 4.8% — this represents an absolute risk increase attributable to using fish oil of just 0.6%

Not to mention, the study also found that even though fish oil users were at a greater risk of developing Afib, fish oil use protected them from transitioning to more severe cardiovascular disease.

Arguably, preventing stroke, heart failure, myocardial infarction, and certainly death are more important outcomes than atrial fibrillation, which we should want to avoid nonetheless. But it’s interesting that most of the media headlines — and even the study authors themselves — choose to focus on the detrimental result in fish oil users rather than the four beneficial results also observed.

Instead of going into some of the other technical issues of the study, I think it would be best to discuss the vast literature (and it is quite vast) supporting the use of omega-3 supplements to promote heart health and prevent cardiovascular disease. Observational studies and randomized controlled trials have largely converged on the idea that fish oil is cardioprotective, and I want to focus on one particular study that seems incredibly relevant to our discussion. This study was published in 2020 and included nearly the exact same group of participants as the current UK Biobank study and similarly, used self-reported fish oil supplementation as the independent variable.

What did this study find? The exact opposite. Regular use of fish oil was associated with a 13% lower risk of all-cause mortality, a 16% lower risk of dying from cardiovascular disease, and a 7% lower risk of incident cardiovascular disease events (i.e., myocardial infarction or stroke).

The evidence for fish oil use strengthens when we look at what is arguably a much more robust measure than self-reported fish oil use — omega-3 fatty acid levels in the blood. One large meta-analysis of cohort studies (including a UK Biobank cohort) found that higher blood DHA levels were associated with a lower risk for all-cause mortality and a lower risk of dying from cardiovascular disease.

Even data from randomized controlled studies of omega-3 supplementation support its benefits, finding that doses of 2–4 grams per day protect against all-cause mortality, cardiovascular disease mortality, and stroke.

It’s important to underscore that other than a slightly elevated risk of Afib, no other studies have found detrimental effects of fish oil supplementation or self-reported fish oil use on cardiovascular outcomes. In my opinion, focusing on this single observational study and ignoring the rest of the literature is missing the forest for the trees. Be careful about what you might read in the headlines about this study, and certainly don’t use it to make decisions about whether or not to supplement with fish oil.

Want more information on fish oil? I’ve put together The Omega-3 Supplementation Guide, a free 12-page guide that has everything you need to know about how to choose the highest-quality omega-3 supplement.

I also talk about fish oil in my most recent Q&A episode (#61), which you can watch in full here. This Q&A also covers hyperbaric oxygen therapy, supplements for kids, sleep strategies, and the impact of curcumin on testosterone.​
 
One thing I noticed since starting to do the health support protocol, which includes fish oils, now that I’m doing it almost daily, I noticed that inflammation on my skin reduced greatly, that includes my skull which I sometimes have a bit of dermatitis or seborrea, but that’s gone! I’m using a special shampoo as well but wasn’t 100% as effective as now that I began this protocol! Taking fish oils with omega-3, 4 days out of 7 days a week.
 
Back
Top Bottom